PWS

Peterson Wealth Services Portfolio holdings

AUM $405M
1-Year Est. Return 38.72%
This Quarter Est. Return
1 Year Est. Return
+38.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$365M
AUM Growth
+$42.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
226
New
Increased
Reduced
Closed

Top Buys

1 +$6.06M
2 +$3.37M
3 +$2.67M
4
ABBV icon
AbbVie
ABBV
+$2.12M
5
CELH icon
Celsius Holdings
CELH
+$636K

Top Sells

1 +$3.5M
2 +$2.78M
3 +$2.28M
4
VUG icon
Vanguard Growth ETF
VUG
+$642K
5
AAPL icon
Apple
AAPL
+$524K

Sector Composition

1 Technology 30.46%
2 Financials 13.69%
3 Consumer Discretionary 11.87%
4 Industrials 9.15%
5 Consumer Staples 6.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
201
Elevance Health
ELV
$74.2B
$1.17K ﹤0.01%
+3
BABA icon
202
Alibaba
BABA
$379B
$1.13K ﹤0.01%
+10
STM icon
203
STMicroelectronics
STM
$20.4B
$1.13K ﹤0.01%
+37
IBOC icon
204
International Bancshares
IBOC
$4.04B
$1.06K ﹤0.01%
+16
PYPL icon
205
PayPal
PYPL
$58.7B
$1.04K ﹤0.01%
+14
EL icon
206
Estee Lauder
EL
$31.6B
$1.03K ﹤0.01%
13
-1,648
SNPS icon
207
Synopsys
SNPS
$73B
$1.02K ﹤0.01%
+2
CRNC icon
208
Cerence
CRNC
$355M
$1.02K ﹤0.01%
+100
QCOM icon
209
Qualcomm
QCOM
$182B
$961 ﹤0.01%
+6
M icon
210
Macy's
M
$5.21B
$956 ﹤0.01%
82
FCX icon
211
Freeport-McMoran
FCX
$56.5B
$954 ﹤0.01%
+22
LMT icon
212
Lockheed Martin
LMT
$108B
$933 ﹤0.01%
+2
AMGN icon
213
Amgen
AMGN
$184B
$845 ﹤0.01%
+3
PWR icon
214
Quanta Services
PWR
$63.9B
$756 ﹤0.01%
+2
SHW icon
215
Sherwin-Williams
SHW
$82.1B
$688 ﹤0.01%
+2
VST icon
216
Vistra
VST
$59.3B
$582 ﹤0.01%
+3
REGN icon
217
Regeneron Pharmaceuticals
REGN
$73.8B
$526 ﹤0.01%
+1
BND icon
218
Vanguard Total Bond Market
BND
$137B
$442 ﹤0.01%
6
PKB icon
219
Invesco Building & Construction ETF
PKB
$289M
$321 ﹤0.01%
4
INTC icon
220
Intel
INTC
$169B
$112 ﹤0.01%
5
-5
BYND icon
221
Beyond Meat
BYND
$476M
$87 ﹤0.01%
25
CSX icon
222
CSX Corp
CSX
$64.7B
-1,125
GD icon
223
General Dynamics
GD
$92.9B
-54
GEHC icon
224
GE HealthCare
GEHC
$32.5B
-4
MRK icon
225
Merck
MRK
$233B
-25,384